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ABSTRACT 
Improving Innate Immunity Through Editing of the 5’ Untranslated Region of Interferon 
Regulatory Factor 7   
  
Mayra Guzman 
Department of Biochemistry and Biophysics  
Texas A&M University 
 
Matthew Lewis 
Department of Animal Science 
Texas A&M University  
 
Research Advisor: Dr. Charles Long 
Department of Veterinary of Physiology and Pharmacology 
Texas A&M University 
 
 
Disease decreases production efficiency and kills millions of animals across all types of 
livestock operations every year. This is severely detrimental to both animal producers and 
consumers from an economic and overall food supply standpoint. Unfortunately, many current 
options for disease control prove to be impractical in various situations. Vaccines are costly to 
administer, can require several boosters over extensive periods of time to become effective, can 
become ineffective due to rapid viral mutations, and some diseases still do not have effective 
treatments or vaccines. Therefore, alternative methods of disease control must be implemented in 
order to better protect livestock and the agricultural industry.  
Type I interferons (IFN) are the first line of defense against viral pathogen invasions in 
animals and humans. Type I IFNs are activated by the master regulator, interferon regulatory 
factor 7 (IRF-7).  In turn, IRF-7 can be inhibited by 2'-5'-oligoadenylate synthase-like protein 1 
(OASL-1), eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), and eukaryotic 
translation initiation factor 4E-binding protein 2 (4E-BP2), (Honda, Yanai et al. 2005). OASL-1, 
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4E-BP, and 4E-BP2 negatively regulate IRF-7 translation and therefore, the transcription of type 
I IFN stimulation (Lee, Kim et al. 2013). Translational regulation of IRF-7 by OASL-1, 4E-BP1, 
and 4E-BP2 occurs at the complex secondary structure of the 5’ untranslated region (UTR) 
upstream of the translational start site. The IRF-7 5’ UTR forms several stem loops, allowing for 
the binding of these inhibitory proteins, therefore, reducing the number of IRF-7 5’ UTR stem 
loop structures may alter the binding of negative regulators and decrease IRF-7 inhibition.  
Genomic editing using the clustered regularly interspaced short palindromic repeats 
(CRISPR) CRISPR/Cas9 system will be used to alter the IRF-7 5’ UTR structure via the stem 
loop sequence. We hypothesize that these DNA sequence modifications will inhibit the binding 
of translational factors and lead to increased IRF-7 expression; ultimately causing an increased 
interferon response, resulting in improved resistance to viruses. This technology may also 
potentially increase resistance against other pathogens, creating genetically engineered animals 
with improved immune systems.   
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CHAPTER I 
INTRODUCTION 
 
Disease control and prevention is a substantial expense for almost any current livestock 
operation. The cost of routine veterinary and preventative care per animal is not normally an 
astronomical number, but it is a substantial part of the operating expenses. However, in larger 
commercial hog operations, disease can spread rapidly throughout the herd and not only affect 
the company financially, but will ultimately hurt the nation’s pork supply. Tremendous amounts 
of money, time, and labor are spent on the prevention of these outbreaks, but inevitably, through 
negligence or viral mutation, an infection will spread through the entire facility’s animal 
population and possibly to neighboring facilities. For example, in 2013, the Porcine Epidemic 
Diarrhea Virus (PEDV) epidemic resulted in large economic and animal losses worldwide, but it 
was exceptionally detrimental to the United States’ economy, export market, and food supply, 
(“Study on Swine”, 2015). A foot and mouth disease epidemic in the United Kingdom in 2001 
resulted in the slaughter of more than 6 million animals, and other countries were also forced to 
kill millions of animals between 2001 and 2010 including, Uruguay, Japan and South Korea, 
among others, (“The costs of animal disease”, 2012). A faster more effective response to these 
viral outbreaks must be implemented, and one promising solution to this problem would be the 
production of livestock with heightened immune responses to viruses. 
 
Disease Control Through Genome Editing 
 There have been multiple studies focused on disease resistance that targets a specific 
gene of interest that is related to only one type of viral infection or disease. One such study 
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conducted at the University of Missouri confirmed that cluster of differentiation 163 gene 
(CD163) knockout pigs are resistant to the type 1 and 2 porcine reproductive and respiratory 
syndrome virus (PRRSV), (Wells, 2016). Another study took this a step further, and generated 
pigs with a deletion in Exon 7 of the CD163 gene. These pigs showed no adverse effects during 
growth and were completely resistant to type 1, sub types 1, 2, and 3, and type 2 PRRSV, 
(Burkhard, 2016). This advancement in immunology could have a substantial effect on the swine 
industry in terms of saving money and keeping animals alive. Similar work was done at Texas 
A&M University and Plum Island where experiments focused on preventing foot and mouth 
disease (FMD) in pigs. With the knowledge that the FMD virus (FMDV) can cause inhibition of 
IFN,IRF-7, and IRF-3 expression, a fused vector of porcine IRF7 and IRF-3 (5D) was created 
and used to successfully inoculate pigs and mice against FMDV infection, (Ramirez, 2014). 
However, resistance to one virus will not be enough to prevent other diseases from plaguing 
livestock. An all-encompassing measure is needed in order to effectively replace current disease 
control measures that simply cannot act quickly or effectively enough. Instead of targeting 
signaling cascades specific to one virus, the upregulation of a gene critical for the induction of 
the immune response in response to pathogens may become an effective resistance measure to 
multiple viruses. 
 
IRF-7 and Translational Regulation  
During a foreign nucleic acid invasion of a host, one of the first defense mechanisms to 
activate is an assembly of cytokines, especially IFNα and IFNβ, from the Type 1 IFN family. 
The production of IFNα and IFNβ, begins with pattern recognition receptors (PRR) on the cell’s 
surface recognizing foreign bodies as pathogen-associated molecular patterns (PAMPs), 
(McNab, Mayer-Barber et al. 2015). Microbial products can be recognized by a multitude of 
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these receptors, but toll-like receptor 4 (TLR4) initiates a powerful pathway for Type 1 IFN 
induction. TLR4 begins this process by using a protein adaptor, TNF receptor-associated factor 3 
(TRAF3), to allow translation of tank binding kinase 1 (TBK1), a protein coding gene, which 
phosphorylates and activates interferon regulatory factor 3 (IRF3), (McNab, Mayer-Barber et al. 
2015). IRF3 expression creates a flood of IFN transcription, producing IFNβ and IFNα4, which 
prompts the transcription of yet another interferon regulatory transcription factor, IRF-7, 
(McNab, Mayer-Barber et al. 2015). IRF-7, known as the master regulator of Type 1 IFN, 
induces the transcription of IFNα and IFNβ, creating a positive feedback loop.  
Although other proteins may activate the Type 1 IFN response,  IRF-7 has proven critical 
in the production of Type 1 IFNs, as shown in a study with IRF-7 deficient mice where type I 
IFN transcription was down regulated or completely inhibited, (Honda, Yanai et al. 
2005).Therefore, IRF-7 is critical in inducing and maintaining interferon expression. Despite the 
importance of IRF-7 in IFN transcription, an unregulated increase in Type 1 IFN will not 
increase the efficiency of a host’s immune system, but instead, create damage such as cancers or 
autoimmune disorders, (McNab, Mayer-Barber et al. 2015). Thus, tight regulation of IRF-7 must 
be in effect, which is done naturally with regulatory proteins. Several laboratories have heavily 
researched IRF-7 in attempt to understand the regulatory mechanisms, particularly those that 
inhibit its translation. 
Currently, the most researched inhibitors of IRF-7 are OASL-1, and the translational 
repressors 4E-BP1 and 4E-BP2. These negative regulatory proteins inhibit the translation of IRF-
7 by different mechanisms. 4E-BP inhibits an elF4F complex that has the ability to recognize the 
5’ cap structure in all nuclear transcribed eukaryotic mRNAs, which facilitates ribosome 
recruitment during the pairing of mRNA with ribosomal unit 40S (Colina, Costa-Mattioli et al. 
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2008). Unit 40S is a part of a preinitiation complex that binds the mRNA which allows it to scan 
the 5’ untranslated region of IRF-7 and bind to it, effectively inhibiting translation of IRF-7, 
(Nahum Soneberg, A. G. H. 2009). The exact region of the IRF-7 5’ UTR which these regulatory 
proteins bind is unknown, (Choi, Oh et al. 2014). However, in a study done at Texas A&M 
University, certain regions in the stem loop structures of IRF-7 5’UTR are elemental in OASL-1 
mediated inhibition and they may also be for 4E-BP, (Choi, 2016). As the 5’ UTR of IRF-7 is 
truncated incrementally from the 3’ end, negative regulation is reduced, IFN production 
increases and the stem loop structure of the IRF-7 5’UTR RNA is altered. This confirmed that 
the complex secondary structure of the 5’ UTR is instrumental in the binding of repressors and 
inhibition of IRF-7 translation, and consequently lead to the knowledge of the sequence 
important for IRF-7 translation, (Ramirez Dissertation, 2014). 
4E-BP and 4E-BP2  
A series of studies illustrated that 4E-BP1 and 4E-BP2 have the ability to regulate IFN 
activity through translational control of IRF7. In these studies, 4E-BP1and 4E-BP2 deficient 
mice were exposed to viral infections and were found with lower viral loads and enhanced 
survival rates. Later, the target of the translational repressor was found to be IRF7 with a 12-fold 
increase in 4E-BP1and 4E-BP2 deficient phenotypic cells, (Colina, R. et al. 2008). Also, 
luciferase reporter gene assays on 4E-BP1and 4E-BP2 deficient cells produced an enhanced 
expression of the 5’UTR-IRF7 luciferase, concluding that possible IRF-7 regulation occurred at 
the RNA secondary structure, (Erickson, Andrea K. et al. 2008). As stated, the 4E-BP1and 4E-
BP2 translational repressors inhibit the elF4F complex, negatively regulating IRF7. These 
repressors bind tightly to the complex when hypophosphorylated and some viral infections have 
the capability of controlling their phosphorylation, (Erickson, Andrea K. et al. 2008).  Also at 
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Texas A&M University, the CRISPR/Cas9 system was utilized and porcine cells were 
engineered to have a knockout of 4E-BP1. As a translational inhibitor of IRF-7, the knockout of 
4E-BP1 showed increased expression of IFNα and IFNβ, (Ramirez, 2015). This work highlighted 
an enhanced antiviral response in porcine cells through the use of the CRISPR/Cas9 system, and 
it also inspired future work with the IRF-7 gene. In order to continue work towards a prevention 
method that will be effective against several livestock viruses, this study focuses specifically on 
inhibiting the binding of the repressors 4E-BP1 and OASL-1 to the 5’ UTR of the IRF-7 gene. 
Therefore, controlling the immune response against viral infection through the IRF-7 5’ UTR 
which binds 4E-BP1 and 4E-BP2 may be promising. 
OASL-1 
It is known that OASL-1 has multiple cellular effects, besides inhibiting translation of the 
5’UTR of IRF-7. OASL-1 is an allosteric activator of RNase L, a Type I interferon induced 
ribonuclease, that destroys all RNA in a cell when activated, inhibiting protein synthesis, and 
causing apoptosis, (Clemens, Michael J. 2005). This pathway is meant to place the cell in an 
antiviral state, but it has the ability to regulate translation of a cell even when uninfected by a 
virus, in response to physiological stress, effectively eliminating healthy cells that may have 
been essential in fighting off viral disease, (Clemens, Michael J. 2005). To understand the 
inhibitory effects of OASL-1, one study used OASL-1 as an antiviral target. These studies 
showed OASL-1 deficient mice had a higher IFN response illustrating its negative regulation on 
the innate immune response, (Lee, 2013). After the induction of type I IFNs by IRF-7, several 
interferon stimulated genes are activated including OASL-1. OASL-1 then down regulates the 
immune response by inhibiting the translation of IRF-7, effectively shutting down the innate 
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immune response. The elimination of this regulation can aid in an increase in IRF-7 and thus an 
increase in IFN, making it a suitable therapeutic antiviral target. 
Considering the inhibitory proteins, OASL-1 and 4E-BP, and their effects on the 
secondary structure of the IRF-7 5’ UTR, to decrease inhibition of IRF7 expression, the stem 
loop structure in the 5’UTR of IRF7 will be modified. Through targeted genome editing with 
CRISPR and Cas9 nuclease, the IRF-7 5’ UTR sequence will be altered, resulting in a change in 
the structural loops necessary for negative regulation. We hypothesize that this will decrease 
inhibition of IRF-7, and increase the host’s innate immune response against viruses without the 
negative consequences of IRF-7 over expression.  
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CHAPTER II 
METHODS 
 
Plasmid Construction 
 The porcine IRF-7 5’ UTR sequence (GenBank: HQ026022, GenBank: FD634523.1 1-
338(EST)) was used to synthesize 6 guide RNA (gRNA) sequences. Due to the poor annotation 
of the porcine genome among known databases, primers were designed outside of the annotated 
region to allow for proper sequencing and amplification of the 5’ UTR. The gRNA sequences 
were then cloned at the BbsI sites of pSpCas9(BB)-2A-GFP (PX458), a gift from Feng Zhang, 
(Addgene plasmid # 48138), a plasmid containing Cas9 nuclease and the green fluorescence 
protein (GFP) genes. A PX458 plasmid without a cloned guide RNA sequence was used as a 
negative control. The gRNA sequences are presented in appendix 1. 
 
Cells and Reagents 
Swine kidney cells (SK6) were used for plasmid transfections. Cells were grown in 
Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) (Gibco, Pittsburg, 
Kansas) supplemented with 10% Fetal Bovine Serum (FBS) (Atlanta Biologics, Flowery Branch, 
GA) and 1% Antibiotic-Antimycotic (Thermo Fisher Scientific, Waltham, MA). The SK6 cells 
were seeded in 6-well plates, at a density close to 1x105, 24 hours before transfection. The cells 
were transfected with the constructed plasmids described above, using Lipofectamine 3000 
(Thermo Fisher Scientific, Waltham, MA). The following day, fluorescence microscopy was 
used to view GFP expression and analyze transfection efficiencies.  
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T7 Endonuclease I Assay  
The SK6 cells were harvested 24 hours post-transfection and used in the T7 
Endonuclease I Assay Kit (New England, Biolabs, Ipswich, MA) to determine the genome 
targeting efficiency of the synthesized gRNA’s. A polymerase chain reaction (PCR) was run 
with forward and reverse primers that cover 756 bp of sequence. The resulting amplicon was 
purified with the QlAquick PCR Purification Kit  (QIAGEN, Hilden, Germany)and used in the 
T7 endonuclease I Assay according to the manufacturer’s protocol. The cleavage bands produced 
by the detection kit were analyzed using gel electrophoresis with a 1.5% agarose gel run for 3 
hours at 90 volts. 
 
Treatment Transfections 
After the gRNAs were tested for functionality, they were utilized in three different 
treatment groups that contained multiple gRNA’s per transfection to allow several gRNAs to 
target the UTR at the same time. This was set up to produce a wide variety of unique mutations 
in cells within the colony. The first treatment group contained gRNAs 1-3 (represented as G:1-3 
in the results), the second group contained gRNAs 4-6 (represented as G: 4-6 in the results), and 
the last treatment contained only gRNAs 1 and 6 (represented as G: 1&6 in the results). The cells 
were plated into 6 wells with the treatment groups described above using Lipofectamine 3000 
(Life Technologies, Carlsbad, CA).  The following day, fluorescence microscopy was used to 
view GFP expression in the colonies.  
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Flow Cytometry and Clonal Propagation of SK6 Cells 
Twenty four hours post transfections, cells in each treatment group were harvested and 
sorted by GFP expression and propidium iodide (PI) staining using flow cytometry (Flow 
Cytometry Core Laboratory at Veterinary Medicine and Biomedical Sciences, Texas A&M 
University). The living cells that were positive for GFP expression and negative for PI were 
sorted singularly into 96 well plates that were then allowed to replicate into larger colonies 
originating from that single cell. The colonies that survived were passed into successively larger 
plates until they were healthy enough to be harvested and either cryogenically preserved or 
grown for further analysis. 
 
DNA Sequencing of Modified SK6 IRF-7 5’UTR 
Selected cells were harvested and DNA was extracted using the QlAquick DNeasy Blood 
and Tissue kit (QIAGEN, Hilden, Germany ) and sent for Sanger sequencing (Laboratory for 
Genome Technology, Texas A&M University). The sequencing data was aligned to the wild type 
5’UTR sequences using the molecular biology suite of benchling.com, and the modifications that 
were found in the sequence were analyzed. Any colonies that represented a consistent mutation 
were matched with specific gRNA’s and any sequences that expressed data that could be 
attributed to a mixed population of cells within the colony, were diluted out in hopes of isolating 
the modified cells.  
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CHAPTER III 
RESULTS 
 
T7 Endonuclease I Assay 
In order to gain insight into the functionality and efficiency of the gRNAs, the T7 
Endonuclease I Assay was performed 24 hours post successful transfection of the constructed 
CRISPR/Cas9 plasmids into SK6 cells. The transfections had a 50-70% efficiency determined 
visually by the expression of GFP. Out of the 6 gRNAs, the T7 endonuclease detected 
heteroduplex DNA in guides 1, 2, 3, and 6, determined by the presence of faint cleavage bands, 
illustrating their functionality (Figure 1). Guide RNA 1 showed several cleavage bands, gRNA 2 
showed 2 cleavage bands, and gRNA 6 showed 1 cleavage band. Due to the faintness bands from 
Figure1. T7 endonuclease 1 assay: Genomic PCR was prepared and tested for CRISPR/CAS 9 induced 
mutations by the T7 endonuclease assay. Target site and primers are found in the index.  
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guides 1,2,3 and 6, guides 4 and 5 were deemed possibly functional. As stated in the methods 
section, the negative control is a PX458 plasmid without a gRNA sequence, and is clearly absent 
of a cleavage band, which ensured that the assay worked properly.  
 
RNA folding predictions from DNA Sequencing of Modified SK6 IRF-7 5’UTR Cells 
 DNA sequencing demonstrated a mutation rate of 54% of all selected GFP positive 
colonies. DNA sequences from transfected cells were aligned to wildtype IRF-7 and those with 
modifications are shown in Figure 2 which also identifies the location of the 6 gRNAs within the 
sequence. RNA folding predictions of the modified IRF-7 5’ UTRs were performed using 
Vienna Websuite. Two databases were used for the UTR sequences, the National Center for 
Biotechnology Information (NCBI) mRNA sequences as well as the Expressed Sequence Tag 
(EST), also provided by the NCBI database. The mRNA sequence is approximately 104 base 
pairs shorter than the EST sequence which showed a fault in the annotation of the 5’ UTR. 
Folding predictions of the cell modifications and wildtype IRF-7 for both NCBI and EST 
sequences are included in figure 2.  
Colony 1 for treatment G1-3 had a 72 base pair deletion between guides 1,2 and 3Colony 
1 for treatment G:1 and 6 had a 191 base pair deletion between guides 1 and 6. Colony 2 for the 
same treatment had a 3 base pair deletion near guide 6. Colony 3 had various insertions of 
different lengths between guides 4, 5 and 6. Colony 4 had a 360 base pair deletion. Colony 1 for 
treatment G: 4-6 had an 83 base pair deletion between guides 4, 5 and 6. Colony 2 had a 72 base 
pair deletion between 4, 5, and 6. Colony 3 had a 42 base pair deletion between 4, 5, and 6. 
Colony 4 had a 4 base pair deletion between 4 and 5. Colony 5 had a 83 base pair deletion 
between 4, 5, and 6. Similarly colony 6 and 7 had a 82 base pair deletion between 4, 5, and 6. 
Figure 2 depicts where the modifications lie on the wildtype 5’UTR IRF-7. Colony 1 and 3 from 
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treatment G:1 and 6 represent knockout modifications, showing large deletions that effectively 
eliminated majority of the IRF-7 5’UTR as show in table 1. All of these modifications effectively 
altered the folding structures. These folding predictions along with the sequence alignments will 
give insight into the important sequences and/or structures for proper binding of proteins OASL-
1 and 4E-BP1 to the IRF-7 5’ UTR. 
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Wildtype IRF-7 
 
G:1-3 Colony 1  
G:1&6 Colony 1  
G:1&6 Colony 2 
G:1&6 Colony 3 
G:4-6 Colony 1 and 5 
G:4-6 Colony 2  
G:4-6 Colony 3 
G:4-6 Colony 4 
G:4-6 Colony 6 and 7 
Figure 2. Guide RNA targets in the IRF-7 NCBI and EST sequence for wildtype IRF-7 and treatment groups 
G:1-3, G:4-6, and G:1&6. The NCBI sequence is from a database collecting DNA information. The expressed 
sequence (EST), database is a collection of sequences from cDNA information. Both sequences contain the 
sequence specific for IRF-7 translation, however the NCBI database contains this sequence only, while the EST 
database shows a more complete picture of the IRF-7 sequence. 
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EST NCBI 
Wildtype 5’UTR IRF-7 
  
Treatment G 1-3: 
  
Treatment G 1& 6: 
  
 
 
 
 
 
 
 
 
 
Colony 1: 3bp D  
Colony 2: 3bp D  
Colony 4: 360 bp D  Colony 4: 360 bp D  
Colony 1: 3 bp D  
Colony 1: 191 bp D  
 
Colony 1: 191 bp D 
 
Colony 2: 3bp D  
Table 1. Model of RNA folding for the wildtype and modified 5’UTR of IRF-7, generated by Vieana Websuite.   
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EST NCBI 
Treatment G 4-6: 
 
 
  
  
 
 
  
  
 
  
Colony 1&5: 83 bp D 
Colony 3:42 bp D  
Colony 4:40 bp D  
Colony 6: 82 bp D  
Colony 1&5: 83 bp 
D 
Colony 2: 72 bp D  Colony 2: 72 bp D  
Colony 3:42 bp D  
Colony 4:40 bp D  
Colony 6: 82 bp D  
Colony 6: 82 bp D  Colony 6: 82 bp D  
Table 1. Model of RNA folding for the wildtype and modified 5’UTR of IRF-7, generated by Vieana Websuite(contd.)   
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CHAPTER IV 
CONCLUSION 
 
CRISPR/Cas9 is an efficient system for inducing genetic modifications in numerous cell 
lines including SK6 cells. The induced modifications produced in the 5’UTR of IRF-7 are 
predicted to alter the secondary stem loop structure of the mRNA, and thus alter any negative 
regulation from 4EB-P1, OASL-1, or any other unknown binding proteins, allowing for 
increased IRF-7 expression and an enhanced immune response through heightened production of 
IFNα and IFNβ.  
Ongoing studies on this project will evaluate each of the cell lines’ response to viral 
challenges and measure changes in type I IFNs, IRF-3, IRF-7, 4EBP, OASL-1, and several other 
interferon stimulated genes that may give insight into how the innate immune system will be 
affected by these modifications. Significant changes in IRF-7 and type I IFN transcript levels 
will be attributed to deletions in specific sites of the sequence, specific stem loop alterations, or a 
combination of the two. Any changes in other immune system gene transcript levels will be 
attributed to an increase in IRF-7 or type I IFNs if present.   
In addition to producing multiple, unique modifications within the 5’ UTR, treatment 
G1&6 was used in hopes of creating a maximal deletion event. G1&6 colony 2 was our expected 
result and will hopefully give an example of unregulated IRF-7 translation and its effects on the 
immune system. Without any repressors inhibiting the translation of IRF-7, there should be 
extremely heightened levels of IFN I response providing a benchmark for unregulated IRF-7 
production. Furthermore, modifications in colonies G1-3 and G4-6 should lead to a more 
controlled increase in IRF-7 expression. Thus, we expect the Type IFN I response to increase 
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due to the alteration of both the gene sequence and the modification the secondary structure. 
Granted, there are more drastic modifications seen in the sequence and number of stem loop 
structures in colonies G1-3 than in G4-6, but according to a study at Texas A&M University, the 
truncation of the 5’ UTR from the 3’ end of the sequence , where the initial 129 base pair 
deletion of the UTR sequence immediately upstream of the translational start site resulted in the 
largest increase in response, the treatment group G4-6 targets that region and is expected to  have 
a much larger effect on the Type 1 IFN , (Ramirez dissertation, 2014). 
 Considering these alterations of the 5’UTR secondary structure, 4EB-P1, 4EB-P2, and 
OASL-1 will not be able to bind to the modified IRF-7 5’ UTR at a normal level because of the 
change in the sequence and consequently, the stem loop structure. This, in turn, should decrease 
their repressive effects on the IRF-7 translation and type I IFN response, increasing IRF-7 and 
type I IFN expression. IRF-3 is also expected to increase since it is critical for the initial 
induction of type I IFNs.  
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APPENDIX  
 
Reverse Primer: GGAACCGTGTTCTGGCTTCA 
Forward Primer: CCGGGGAGACGAAACTTCC 
Guide 1: 5’ CTCTGGCCACGACGTTGCCC 3’ 
Guide 2: 5’ GCCAGGTGTCACGGGTGTTG 3’ 
Guide 3: 5’ CTGGCCACACTCACTACCTG 3’ 
Guide 4: 5’ AGGTGTTAACCGCAGGTGAG 3’ 
Guide 5: 5’ CGTGGTCAGAGCTCTCGCCG 3’ 
Guide 6: CCACGCCCAGTCCTTGCAGA 
 
 
 
 
 
 
 
 
 
 
 
 
